Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | PKM | P14618 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 9/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31501264 | 0.86 | ACHE (0.57) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL4071777 | 0.84 | MAPT (0.65) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL24704424 | 0.83 | KDM4E (0.60) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL5799814 | 0.80 | METAP2 (0.59) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL31501268 | 0.80 | SMN1; SMN2 (0.52) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL27404178 | 0.75 | KDM4E (0.50) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL31501263 | 0.74 | CYP1A2 (0.61) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL22481864 | 0.70 | MAPT (0.69) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL31284699 | 0.69 | ACHE (0.48) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL31283817 | 0.69 | ACHE (0.45) | MAPTKDM4EALDH1A1PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | FUJIFILM CORPORATION (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | FUJIFILM CORPORATION (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| WO-2022255228-A1 | COMPOSITION, CURED PRODUCT OR COMPACT, OPTICAL MEMBER, AND LENS | 富士フイルム株式会社 | 2022-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | POLR1A, RAD51, POLR2A | MAPT 419/4885KDM4E 2324/4885ALDH1A1 1702/4885 |
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | SPG11, HAT1, ASS1 | MAPT 1976/4885KDM4E 4186/4885ALDH1A1 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.